NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.
| Publicado en: | Psychopharmacology Vol. 169; no. 3/4; pp. 215 - 216 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
2003
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104332663&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 104332663 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00333158 EJD jtl: Psychopharmacology issn: 00333158 maglogo: N pubinfo: dt: 2003 vid: 169 iid: 3/4 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 104332663 2011953986 10.1007/s00213-003-1582-z 104332663 ppf: 215 ppct: 1 formats: fmt: @attributes: type: P tig: atl: NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. aug: au: Krystal, John H. D'Souza, D. Cyril Mathalon, Daniel Perry, Edward Belger, Aysenil Hoffman, Ralph affil: Schizophrenia Biological Research Center (116-A), VA Connecticut Healthcare System, 950 Campbell Ave., West Haven, CT 06516, USA.; Department of Psychiatry, Yale University, New Haven, CT 06510, USA.; Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, 34 Park St., New Haven, CT 06519, USA. sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|